BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Career Advice

  4 Reasons Why Employee Engagement is More Important than Ever for Companies

  What is the culture like at your company? Are employees motivated to do their best work? Is your company using employee engagement strategies to improve productivity?

  August 2, 2021

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Drug Development

  AbbVie Enjoys Strong Second Quarter as Rinvoq Gears Up to Succeed Humira

  The company saw global net revenue of $13.9 billion during the second quarter, an increase of 33.9%. Sales were primarily driven by its immunology portfolio, which generated $6.12 billion.

  August 2, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Vaxart Scores IND For S-Only Oral Tablet COVID-19 Vaccine Candidate

  The drug, created by Vaxart, has just completed its Phase I trial and had submitted an Investigational New Drug application to move forward.

  August 2, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  FDA

  AstraZeneca’s FDA Approval Brings New Hope to the Lupus Community

  Seventeen years after buying global rights, AstraZeneca is finally announcing a win for the lupus community with an FDA approval for Saphnelo.

  August 2, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Job Trends

  Bio NC Continues to Boom as More Companies Settle and Expand

  North Carolina’s biopharma business continues to expand at a rapid pace. Not only has the state’s hub in the Research Triangle Park continued to prosper, but companies are expanding in other areas across the state as well.

  August 2, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Ophthalmology Companies See Global Opportunities for Next-Gen, Non-Invasive Therapies

  Ophthalmology has become a focal point for private equity and venture capitalists in the past 18 months, despite being a small niche in the biopharmaceutical space.

  August 2, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  Ipsen Goes All In on Neuro with $1 Billion+ Deal For Exicure’s Oligonucleotides

  The deal will see Ipsen and Exicure collaborating to research, develop, and commercialize Spherical Nucleic Acids to treat AS and HD.

  August 2, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Pharm Country

  Roivant Invests $200 Million in Immunovant to Advance Autoimmune Disorder Drug Candidate

  The financing will be used to advance the company’s IMVT-1401 candidate across several different autoimmune disorder indications.

  August 2, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Policy

  GOP Presses Lab Leak Investigation as Conflicting Evidence Mounts

  Rep. Michael McCaul issued a third installment today into the origins of the COVID-19 virus and blames the pandemic on a leak from the Wuhan Institute of Virology in China.

  August 2, 2021

   · 

  7 min read

   · 

  Mark Terry
• 

  Business

  InterVenn, T-knife and Zentara Bolster Missions with New Funding

  The three companies will use their proceeds to support the development of their pipelines through additional business development opportunities.

  August 2, 2021

   · 

  3 min read

   · 

  Alex Keown